Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Press Release - Theralase(R) Announces Brokered LIFE Financing

<< Previous

Bullboard Posts

Next >>

Comment by charlierockon Oct 23, 2023 8:52pm

211 Views

Post# 35697418

RE:RE:RE:RE:New Press Release - Theralase(R) Announces Brokered LIFE Financing

The announced financing is no big deal. It was expected so probably baked into the cake as far as the SP is concerned. As for listening to so called promoters, who needs them. The data is my promoter and it says THE FUTURE LOOKS BRIGHT for our ACT.

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”